Literature DB >> 8945064

Spatial distribution of QT intervals: an alternative approach to QT dispersion.

P Van Leeuwen1, B Hailer, M Wehr.   

Abstract

QT dispersion (QTd) describes the heterogeneity of ventricular repolarization on the basis of the temporal range of QT intervals as measured in the 12-lead ECG. We examined the spatial distribution of QTd using multichannel magnetocardiograms (MCGs), which noninvasively register changes in magnetic field strength at 37 sites over the heart. As in ECG, the MCG signal in each channel may be used to measure QT interval. By calculating QT deviation from QTmin at each site, one can reconstruct the spatial distribution of QTd. Analysis of spatial QTd in ten healthy subjects and ten patients after acute myocardial infarction (MI) showed clear differences in spatial distribution. The healthy subjects generally displayed shorter QT intervals along a line corresponding to the approximate position of the septum with longer intervals in plateaus in the upper right and lower left. Spatial QTd of the post-MI patients deviated from this pattern, often displaying a sharp rise in QT duration over specific areas, which could be related to functional and morphological disturbances. The quantification of local irregularities as well as the overall pattern on the basis of a smoothness index allowed better discrimination between healthy subjects and post-MI patients than QTd. Distribution patterns of QTd which reflect local repolarization alterations may thus represent a more differentiated marker for pathology and risk.

Entities:  

Mesh:

Year:  1996        PMID: 8945064     DOI: 10.1111/j.1540-8159.1996.tb03248.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  8 in total

1.  Magnetocardiographic assessment of healed myocardial infarction.

Authors:  Helena Hänninen; Miia Holmström; Paula Vesterinen; Milla Karvonen; Heikki Väänänen; Lasse Oikarinen; Markku Mäkijärvi; Jukka Nenonen; Kirsi Lauerma; Toivo Katila; Lauri Toivonen
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-07       Impact factor: 1.468

2.  Has magnetocardiography a clinical future?

Authors:  H D Esperer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-09

3.  [Has the magnetocardiography a clinical future?].

Authors:  H D Esperer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-09

4.  Earliest time of change in QT dispersion after stenting in patients with single vessel coronary artery disease.

Authors:  Gholam Reza Rezaian; Hooman Shariati Ghadicolay; Mohammad Bagher Sharif Kazemi; Mahmood Zamirian; Kamran Aghasadeghi; Shahed Rezaian
Journal:  Int J Angiol       Date:  2007

5.  A method for detecting myocardial abnormality by using a total current-vector calculated from ST-segment deviation of a magnetocardiogram signal.

Authors:  A Kandori; H Kanzaki; K Miyatake; S Hashimoto; S Itoh; N Tanaka; T Miyashita; K Tsukada
Journal:  Med Biol Eng Comput       Date:  2001-01       Impact factor: 2.602

6.  [Relevance of magnetocardiography in coronary artery disease and myocardial infarction].

Authors:  B Hailer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-09

7.  Spatial repolarization heterogeneity detected by magnetocardiography correlates with cardiac iron overload and adverse cardiac events in beta-thalassemia major.

Authors:  Chun-An Chen; Meng-Yao Lu; Shinn-Forng Peng; Kai-Hsin Lin; Hsiu-Hao Chang; Yung-Li Yang; Shiann-Tarng Jou; Dong-Tsamn Lin; Yen-Bin Liu; Herng-Er Horng; Hong-Chang Yang; Jou-Kou Wang; Mei-Hwan Wu; Chau-Chung Wu
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

8.  MAGNETO cardiography parameters to predict future Sudden Cardiac Death (MAGNETO-SCD) or ventricular events from implantable cardioverter defibrillators: study protocol, design and rationale.

Authors:  Thomas Lachlan; Hejie He; Kavi Sharma; Jamal Khan; Kim Rajappan; Adrian Morley-Davies; Ashish Patwala; Harpal Randeva; Faizel Osman
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.